本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Amneal Pharmaceuticals, Inc.

17.01
+0.14000.83%
盤前17.050.0400+0.24%08:06 EDT
成交量:115.77萬
成交額:1,963.28萬
市值:54.26億
市盈率:35.38
高:17.11
開:17.00
低:16.73
收:16.87
52周最高:19.26
52周最低:9.49
股本:3.19億
流通股本:1.91億
量比:0.66
換手率:0.61%
股息:- -
股息率:- -
每股收益(TTM):0.4808
每股收益(LYR):0.2200
淨資產收益率:613.02%
總資產收益率:8.60%
市淨率:164.31
市盈率(LYR):77.32

資料載入中...

2024/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/08

重要事件披露

Form 8-K - Current report
2024/10/31

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/01

重要事件披露

Form 8-K - Current report
2024/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/09

重要事件披露

Form 8-K - Current report
2024/05/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/13

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/05/03

重要事件披露

Form 8-K - Current report
2024/04/24

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/14

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]